Success Metrics

Clinical Success Rate
92.4%

Based on 73 completed trials

Completion Rate
92%(73/79)
Active Trials
26(20%)
Results Posted
36%(26 trials)
Terminated
6(5%)

Phase Distribution

Ph not_applicable
40
31%
Ph phase_1
27
21%
Ph phase_2
35
27%
Ph phase_3
17
13%
Ph early_phase_1
4
3%
Ph phase_4
7
5%

Phase Distribution

31

Early Stage

35

Mid Stage

24

Late Stage

Phase Distribution130 total trials
Early Phase 1First-in-human
4(3.1%)
Phase 1Safety & dosage
27(20.8%)
Phase 2Efficacy & side effects
35(26.9%)
Phase 3Large-scale testing
17(13.1%)
Phase 4Post-market surveillance
7(5.4%)
N/ANon-phased studies
40(30.8%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

91.3%

73 of 80 finished

Non-Completion Rate

8.8%

7 ended early

Currently Active

26

trials recruiting

Total Trials

130

all time

Status Distribution
Active(30)
Completed(73)
Terminated(7)
Other(20)

Detailed Status

Completed73
Recruiting20
unknown20
Active, not recruiting6
Terminated6
Not yet recruiting4

Development Timeline

Analytics

Development Status

Total Trials
130
Active
26
Success Rate
92.4%
Most Advanced
Phase 4

Trials by Phase

Early Phase 14 (3.1%)
Phase 127 (20.8%)
Phase 235 (26.9%)
Phase 317 (13.1%)
Phase 47 (5.4%)
N/A40 (30.8%)

Trials by Status

not_yet_recruiting43%
withdrawn11%
recruiting2015%
completed7356%
unknown2015%
active_not_recruiting65%
terminated65%

Recent Activity

Clinical Trials (130)

Showing 20 of 130 trialsScroll for more
NCT05548452Phase 1

Intestinal Microbiota Transplant in Alcohol-Associated Liver Disease

Recruiting
NCT01631617Phase 2

Effects of Treatments on Atopic Dermatitis

Recruiting
NCT07219498Not Applicable

Effects of a 5-Week Probiotic Supplementation Intervention on Markers of Delayed Onset Muscle Soreness

Recruiting
NCT07076849Phase 2

Probiotic Supplementation in Optimizing Iron and Hematological Status Among Pregnant Females

Recruiting
NCT07282821Phase 2

Bempedoic Acid Therapy for Polycystic Kidney Disease

Not Yet Recruiting
NCT07415720Not Applicable

Artichoke By-products Rich in Hydroxycinnamic Acids and Mediterranean Diet for Type 2 Diabetes Prevention.

Recruiting
NCT06638502Phase 1

Safety of HRX215 in Patients After Minor and Major Liver Resection

Recruiting
NCT06649981Phase 1

Aging Resilience Through Microbiota Optimization and Regulation

Active Not Recruiting
NCT04685590Phase 2

Senolytic Therapy to Modulate the Progression of Alzheimer's Disease (SToMP-AD) Study

Active Not Recruiting
NCT04580472Phase 4

Utility of Single-dose Oral Antibiotic Prophylaxis in Prevention of Surgical Site Infection in Dermatologic Surgery

Active Not Recruiting
NCT07484412Not Applicable

Efficacy and Safety of Encapsulated Bifidobacterium Longum BBH016 in Subjects With Lower Gastrointestinal Symptoms

Active Not Recruiting
NCT07052890Not Applicable

Curcumin, Vitamin D and Green Tea in IBS-D

Completed
NCT07145658Not Applicable

Multivitamin for Health and Cognition

Completed
NCT06017609Phase 2

Evaluate Efficacy, Safety and Tolerability of JTT-861 in Subjects With Heart Failure With Reduced Ejection Fraction

Active Not Recruiting
NCT05988463Phase 1

Dose-Escalation Study of Artesunate Patients With IPF

Recruiting
NCT05598112Early Phase 1

Effect of Gut Microbiome Intervention on Aging Via Oral FMT

Recruiting
NCT07303088Not Applicable

Effects of L-carnitine and Coenzyme Q10 Supplementation on Oxidative Stress in Tunisian Hemodialysis Patients.

Completed
NCT07269821Not Applicable

Evaluation of a Nutritional Intervention With Dietary Supplements in People Who Have Recently Lost Weight: Effects on Body Composition, Emotional Health, and Gut Microbiota

Completed
NCT07106580Phase 1

Safety and Efficacy of Lyophilized Fecal Microbiota Transplantation Via Capsules for Intestinal Multidrug-resistant Bacteria Decolonization

Recruiting
NCT07262346Phase 1

The Phase Ⅰd Clinical Trial of Hydronidone Capsules

Not Yet Recruiting

Drug Details

Intervention Type
DRUG
Total Trials
130